Breast Cancer

Breast Cancer
2024-12-17T01:21:22.050Z

AAA603-NeoB-Breast

AAA603-NeoB-Breast
Breast cancer

A Phase I/II open label multi-centre trial of 177Lu Lu-Neo-B in combination with capecitabine in adult patients with gastrin releasing peptide receptor positive oestrogen receptor positive human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine therapy in combination with CDK 4/6 inhibitor

A Phase I/II open label multi-centre trial of 177Lu Lu-Neo-B in combination with capecitabine in adult patients with gastrin releasing peptide receptor positive oestrogen receptor positive human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine therapy in combination with CDK 4/6 inhibitor

Trial overview

Clinical Area

Theranostics

Disease / Condition

Breast Cancer

Study Phase

I/ll

Trial Identifiers
GenesisCare Location(s)
Cabrini (Gandel Wing)
location pin icon

Cabrini Hospital Malvern, Level B4, Gandel Wing, 183 Wattletree Road, Malvern, VIC, 3144, Australia

phone icon (03) 9597 6900 email icon cabrinireception@genesiscare.com
VIC
Cabrini (Gandel Wing)
Principal Investigator(s)
Nuclear Medicine Physician

A/Prof Dinesh Sivaratnam

MBBS FRACP FAANMS, B.Med.Sci.

A/Prof Dinesh Sivaratnam
location pin icon

Cabrini (Gandel Wing)

View Profile
Profile Image - A/Prof Dinesh Sivaratnam

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.